Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment

Table 3 Function and bother scores (mean ± standard deviation; median) in dependence on Charlson Comorbidity Index (CCI)

CCI	<5	5	>5
urinary function*	*94 ± 12; 100*	*93 ± 12; 100*	*89 ± 16; 94*
continence function*	*92 ± 17; 100*	*90 ± 18; 100*	*82 ± 25; 100*
irritative/obstructive function	97 ± 12; 100	97 ± 9; 100	96 ± 13; 100
urinary bother*	*85 ± 19; 93*	*84 ± 16; 89*	*77 ± 22; 82*
continence bother*	*93 ± 20; 100*	*93 ± 20; 100*	*86 ± 29; 100*
irritative/obstructive bother*	*84 ± 19; 90*	*83 ± 16; 85*	*76 ± 21; 80*
bowel function	93 ± 9; 96	93 ± 8; 96	91 ± 10; 96
bowel bother	94 ± 13; 100	94 ± 11; 100	92 ± 15; 100
sexual function*	*49 ± 22; 51*	*37 ± 24; 37*	*31 ± 24; 29*
*sexual bother*†	*68 ± 31; 75*	*64 ± 34; 69*	*52 ± 36; 50*
hormonal function	92 ± 14; 100	90 ± 13; 100	90 ± 13; 100
hormonal bother	92 ± 13; 100	90 ± 15; 96	90 ± 15; 96

ISSN: 1471-2407